SEARCH RESULT

Total Matching Records found : 523

Tribals have lost their farmlands over the century -KD Singh

The marginalisation of tribals in the last few decades has been enormous. Tribals have lost out in agriculture, and their forests also stand depleted, writes KD Singh In 2006, the Prime Minister described the Maoist threat as “the single biggest internal security challenge ever faced by the country” and suggested development in insurgency-affected regions as the key remedy. In 2009, the Union Government announced a new nationwide initiative, the ‘Integrated Action...

More »

Capital shuts door on Burmese refugees-Anahita Mukherji

Over 2000 impoverished Burmese asylum-seekers from across India, camping on the streets of Delhi pleading for refugee status were dealt a double whammy. On Tuesday afternoon, even as a delegation of Burmese met UN officials to sort out their problems, they were forced out of their temporary shelter in Vasant Kunj by police, dumped into buses and rickshaws and told to find their way home. To make matters worse, their...

More »

A healthier India: Need to resolve conflict between drug price controls, innovation and affordable healthcare-David Taylor

The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...

More »

Bayer to challenge Cipla’s decision to cut price of cancer drug

-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...

More »

Estimating poverty properly

-The Business Standard How to take hot air out of the poverty debate Once again, poverty estimations are creating a needless debate over what is a modest measurement problem. For many years since 1973, the government had followed a simple formula: if a household could not afford to buy a minimal number of calories and clothing for its members, it was deemed as a household below the Planning Commission poverty line....

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close